KRKabiru Afolarin Rabiu

Kabiru Afolarin Rabiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kabiru Afolarin Rabiu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Accuracy of clinical risk factor-based models as a screening test for detecting gestational diabetes mellitus in a low-resource setting

    by Olayinka Comfort Senbanjo, Fatimat Motunrayo Akinlusi, Kabiru Afolarin Rabiu

    Objective: Screening and diagnosing gestational diabetes mellitus (GDM) usually requires a 2-hour, 75 g oral glucose tolerance test (OGTT), which can be challenging for both patients and healthcare systems. Alternative clinical risk factor-based models have been suggested but have not been extensively tested, particularly in low-resource countries. This study aimed to evaluate the accuracy of these risk factor-based models as screening tools. Subject and methods: This prospective cohort study involved 400 consenting pregnant women receiving antenatal care in Lagos, [...] Abstract Objective: Screening and diagnosing gestational diabetes mellitus (GDM) usually requires a 2-hour, 75 g oral glucose tolerance test (OGTT), which can be challenging for both patients and healthcare systems. Alternative clinical risk factor-based models have been suggested but have not been extensively tested, particularly in low-resource countries. This study aimed to evaluate the accuracy of these risk factor-based models as screening tools. Subject and methods: This prospective cohort study involved 400 consenting pregnant women receiving antenatal care in Lagos,


  • Open Access

    Prenatal anaemia and risk of postpartum haemorrhage: a cohort analysis of data from the Predict-PPH study

    by Kehinde S. Okunade, Adebola A. Adejimi, Ayokunle M. Olumodeji, Atinuke Olowe, Olufemi A. Oyedeji, Iyabo Y. Ademuyiwa, Hameed Adelabu, Eselobu Toks-Omage, Austin C. Okoro, Nosimot Davies, et al.

    Background: Most previous clinical studies investigating the connection between prenatal anaemia and postpartum haemorrhage (PPH) have reported conflicting results. Objectives: We examined the association between maternal prenatal anaemia and the risk of PPH in a large cohort of healthy pregnant women in five health institutions in Lagos, Southwest Nigeria. Methods: This was a prospective cohort analysis of data from the Predict-PPH study that was conducted between January and June 2023. The study enrolled n = 1222 healthy pregnant women giving birth in five hospitals in Lagos, Nigeria. The study outcome, WHO-defined PPH, is postpartum blood loss of at least 500 milliliters. We used a multivariable logistic regression model with a backward stepwise conditional approach to examine the association between prenatal anaemia of increasing severity and PPH while adjusting for confounding factors. Results: Of the 1222 women recruited to the Predict-PPH study between January and June 2023, 1189 (97·3%) had complete outcome data. Up to 570 (46.6%) of the enrolled women had prenatal anaemia while 442 (37.2%) of those with complete follow-up data had WHO-defined PPH. After controlling for potential confounding factors, maternal prenatal anaemia was independently associated with PPH (adjusted odds ratio = 1.37, 95% confidence interval: 1.05–1.79). However, on the elimination of interaction effects of coexisting uterine fibroids and mode of delivery on this association, a sensitivity analysis yielded a lack of significant association between prenatal anaemia and PPH (adjusted odds ratio = 1.27, 95% confidence interval: 0.99–1.64). We also recorded no statistically significant difference in the median postpartum blood loss in women across the different categories of anaemia (P = 0.131). Conclusion: Our study revealed that prenatal anaemia was not significantly associated with PPH. These findings challenge the previously held belief of a suspected link between maternal anaemia and PPH. This unique evidence contrary to most previous studies suggests that other factors beyond prenatal anaemia may contribute more significantly to the occurrence of PPH. This highlights the importance of comprehensive assessment and consideration of various maternal health factors in predicting and preventing this life-threatening obstetric complication.


  • Open Access

    Risk factors for postcesarean wound infection in a tertiary hospital in Lagos, Nigeria

    by Kabiru Afolarin Rabiu, Fatimat Motunrayo Akinlusi, Adeniyi Abiodun Adewunmi, Taiwo Ganiyat Alausa, Idayat Adejumoke Durojaiye

    Background: There has been a global increase in cesarean section rates. While this has improved perinatal outcome, it is associated with complications such as wound infection. We determined risk factors for cesarean section wound infection in a tertiary hospital in Lagos, Nigeria. Materials and Methods: We prospectively studied a cohort of 906 women who had cesarean section at the Obstetrics Unit of the Lagos State University Teaching Hospital between January 1, 2011, and December 31, 2011. A comparison was made between 176 women who had wound infection and 730 women who did not using logistic regression. Results: Of the 2134 deliveries during the study, 906 (42.5%) had cesarean section and of which 176 (19.4%) had wound infection. Independent risk factors for wound infection were: preoperative anemia (adjusted odds ratio [aOR] = 1.88; 95% confidence intervals [CI] = 1.03–3.41; P = 0.0396), presence of diabetes mellitus (aOR = 7.94; 95% CI = 1.60–39.27; P = 0.0111), HIV infection (aOR = 6.34; 95% CI = 1.74–23.06; P = 0.0051), prolonged operation time (aOR = 2.30; 95% CI = 1.19–4.42; P = 0.0127), excessive blood loss at surgery (aOR = 5.05; 95% CI = 2.18–11.66; P = 0.0002), and chorioamnionitis (aOR = 9.00; 95% CI = 1.37–59.32; P = 0.0224). Conclusions: Patients with HIV infection, diabetes mellitus, preoperative anemia and chorioamnionitis have an increased risk of postcesarean wound infection as is when surgical time exceeds 1 h or when associated with blood loss >11.


  • Open Access

    Parental acceptance of human papillomavirus vaccination for adolescent girls in Lagos, Nigeria

    by KabiruA Rabiu, Taiwo G Alausa, Fatimat M Akinlusi, NosimotO Davies, KhadijahA Shittu, Oluwarotimi Ireti Akinola

    Background and Aims: Human papillomavirus (HPV) vaccination is recommended for adolescent girls and would offer a long-term solution to cervical cancer especially in developing countries. However, parental perception and acceptance is a critical success factor. This study examined the degree of parental acceptance of HPV vaccination for adolescent secondary-school girls in Lagos, Nigeria. Materials and Methods: A descriptive cross-sectional survey of adolescent girls' parents was undertaken in two urban and two rural secondary schools in Lagos. Univariate and multivariate analysis were carried out using logistic regression to determine correlates of parental acceptance of HPV vaccine. Results: Of the 318 respondents, 45.9% had poor knowledge of cervical cancer and HPV infection, whereas 29.6% had good knowledge. Majority (54.7%) also had poor knowledge of HPV vaccine, whereas 26.7% had good knowledge. Most (72%) would vaccinate their daughters if vaccines were free, whereas only 35.5% would, if not free. Poor knowledge of cervical cancer and HPV infection significantly reduced the likelihood of vaccination even if free (adjusted odds ratio [OR] =0.48; 95% confidence interval [CI] =0.24–0.94; P = 0.0325), whereas good knowledge of HPV vaccines (adjusted OR = 6.11; 95% CI = 1.37–27.34; P = 0.018) and tertiary education in the mother (adjusted OR = 29.17; 95% CI = 3.98–214.08; P = 0.0009) increased the likelihood, if not free. Conclusion: HPV vaccination was acceptable to most parents only if offered free. Poor knowledge of cervical cancer, HPV infection, and vaccine may hinder acceptability. It is recommended that HPV vaccination is offered free through the National Programme on Immunization in Nigeria.


  • Open Access

    Comparison of papanicolaou smear quality with the anatomical spatula and the cytobrush–spatula: A single-blind clinical trial

    by Kabiru Afolarin Rabiu, UgochiO Nzeribe-Abangwu, Fatimat Motunrayo Akinlusi, Taiwo Ganiyat Alausa, Idayat Adejumoke Durojaiye

    Background: The Papanicolaou (Pap) smear is a standard test for cervical cancer screening; however, the most important challenge is high false-negative results due to inadequate sampling using the Ayres spatula. The cytobrush has been used in combination with the Ayres spatula (cytobrush– spatula) in an attempt to improve the quality of smears with additional costs. The aim of this study was to compare the Pap smear quality with the anatomical spatula (with extended tip) and the cytobrush–spatula. Materials and Methods: This was a prospective single-bind clinical trial. One hundred and ten sexually active women aged between 22 and 65 years were randomized into groups, each having two smears at the same time: one with a cytobrush–spatula and another with an anatomical spatula. Fifty-five patients were randomized to have the anatomical spatula first to obtain their smears and 55 were randomized to have the cytobrush–spatula first to obtain their smears. Slides were assessed by a pathologist. Results: There was no significant difference in the quality of the smears using the two devices with respect to cellular adequacy (P = 0.3532), absent blood staining (P = 0.7766), presence of endocervical cells (P = 0.3502), and evidence of transformation zone sampling using the Bethesda criteria (0.4028). Kappa analysis shows moderate inter-rater agreement between the two devices by ability to show evidence of transformation zone using British Society for Clinical Cytology and Bethesda criteria. Conclusions: There was no significant difference in the quality of smears obtained using the two different methods. The anatomical spatula can be used as a single device in conventional cytology in place of the cytobrush–spatula with the aim of improving the quality of smears without necessarily increasing the cost.


  • Open Access

    Risk factors for maternal mortality associated with eclampsia presenting at a Nigerian tertiary hospital

    by Kabiru Afolarin Rabiu, Adeniyi Abiodun Adewunmi, Tawakwalit Abimbola Ottun, Fatimat Motunrayo Akinlusi, Adewunmi Adeoye Adebanjo, Taiwo Ganiyat Alausa

    Background: Eclampsia remains a leading contributor to maternal mortality, particularly in developing countries, and remains a challenge even to the most experienced obstetrician. We aimed to determine the factors associated with maternal mortality in eclamptics at the Lagos State University Teaching Hospital (LASUTH), Nigeria, in order to suggest ways to prevent this avoidable tragedy. Materials and methods: Data were prospectively collected with the aid of a specially designed proforma from January 1, 2011 to December 31, 2012. Comparison was made between the patients who died (cases) and the survivors (control). Univariate and multivariate analyses were carried out using logistic regression. Results: The case fatality rate was 19.4%. Factors independently associated with mortality were as follows: period between onset of seizures to arrival in LASUTH >12 hours (adjusted OR=22.04; 95% CI=4.62–104.95; P=0.001), vaginal delivery (adjusted OR=10.96; 95% CI=2.54–47.27; P=0.0013), presence of aspiration pneumonitis (adjusted OR=7.77; 95% CI=2.37–25.46; P=0.0007), and presence of renal failure (adjusted OR=7.09; 95% CI=2.14–23.48; P=0.0014). The use of magnesium sulfate reduced the risk of mortality (adjusted OR=0.25; 95% CI=0.09–0.72; P=0.0104). Conclusion: Maternal mortality in patients with eclampsia was associated largely with preventable factors. The use of standard obstetric services, prompt referral of patients for definitive care, and the use of simplified dosing regimen of magnesium sulfate may improve its utilization and also improve maternal outcome.


  • Delays in presentation and management of ovarian cancer in Lagos, Nigeria

    by K. A. Rabiu, O. I. Akinola, A. A. Adewunmi, A. O. Fabamwo, M. O. Adedeji, A. O. Popoola

    This study highlights the extent of delays in the presentation and management of ovarian cancer at the Lagos State University Teaching Hospital. A total of 37 histologically confirmed epithelial ovarian cancer cases managed from January 2004 to December 2008 were analysed. The time interval between onset of symptoms and seeking healthcare, was 36.1 ± 40.8 weeks; between seeking healthcare and referral to tertiary hospital, was 22.7 ± 30.4 weeks; and the overall time interval from onset of symptoms to presentation for definitive care, was 52.0 ± 51.8 weeks. Private hospitals (35.1%) and herbal homes (21.6%) were the commonest facilities first visited. A total of 32 (86.5%) of the patients presented in stages III and IV. The overall compliance rate for recommended chemotherapy was 11.1%. Ovarian cancer in Lagos, Nigeria is characterised by patient-related delays in presentation, provider-related delays in referrals and poor compliance with recommended chemotherapy.